These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12211889)

  • 21. Treatment-refractory depression successfully treated with the combination of mirtazapine and lithium.
    Moustgaard G
    J Clin Psychopharmacol; 2000 Apr; 20(2):268. PubMed ID: 10770470
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment with mirtazapine and venlafaxine increases noradrenaline excretion in depressed patients.
    Lecei O; Lederbogen F; Gronau W; Scharnholz B; Terhardt J; Schilling C; Gilles M; Kopf D; Roth HJ; Weber-Hamann B; Deuschle M
    J Clin Psychopharmacol; 2012 Aug; 32(4):574-6. PubMed ID: 22760352
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of mirtazapine in an adult with refractory anorexia nervosa and comorbid depression: a case report.
    Safer DL; Darcy AM; Lock J
    Int J Eat Disord; 2011 Mar; 44(2):178-81. PubMed ID: 20127940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combining venlafaxine and mirtazapine for the treatment of major depression with dysthymia--"double depression"].
    Ladeira RB; Cunha FT; Salgado JV; Teixeira AL; Nicolato R
    Braz J Psychiatry; 2008 Sep; 30(3):299-300. PubMed ID: 18833439
    [No Abstract]   [Full Text] [Related]  

  • 25. The pharmacologic rationale for the clinical use of antidepressants.
    Pinder RM
    J Clin Psychiatry; 1997 Nov; 58(11):501-8. PubMed ID: 9413422
    [No Abstract]   [Full Text] [Related]  

  • 26. Improved insulin sensitivity in 51 nondiabetic depressed inpatients remitting during antidepressive treatment with mirtazapine and venlafaxine.
    Weber-Hamann B; Gilles M; Schilling C; Onken V; Frankhauser P; Kopf D; Lederbogen F; Deuschle M
    J Clin Psychopharmacol; 2008 Oct; 28(5):581-4. PubMed ID: 18794665
    [No Abstract]   [Full Text] [Related]  

  • 27. Mirtazapine does not influence tetrahydrodeoxycorticosterone levels in depressed patients.
    Schüle C; Baghai TC; di Michele F; Eser D; Pasini A; Romeo E; Rupprecht R
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):308-13. PubMed ID: 20218794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mirtazapine in the treatment of panic disorder.
    Carli V; Sarchiapone M; Camardese G; Romano L; DeRisio S
    Arch Gen Psychiatry; 2002 Jul; 59(7):661-2. PubMed ID: 12090820
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: a pilot study.
    Winokur A; Sateia MJ; Hayes JB; Bayles-Dazet W; MacDonald MM; Gary KA
    Biol Psychiatry; 2000 Jul; 48(1):75-8. PubMed ID: 10913511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mirtazapine-associated dose-dependent and asymptomatic elevation of hepatic enzymes.
    Adetunji B; Basil B; Mathews M; Osinowo T
    Ann Pharmacother; 2007 Feb; 41(2):359. PubMed ID: 17244643
    [No Abstract]   [Full Text] [Related]  

  • 31. Hyperglycaemia secondary to mirtazapine therapy in a 37-year-old man.
    Chen R; Lopes J
    Aust N Z J Psychiatry; 2008 Nov; 42(11):990-1. PubMed ID: 18946939
    [No Abstract]   [Full Text] [Related]  

  • 32. Venlafaxine, but not mirtazapine lowers retinol-binding protein 4 serum concentrations in nondiabetic depressed patients.
    Deuschle M; Angermeier T; Westphal S; Lederbogen F; Gilles M; Frankhauser P; Schilling C; Onken V; Weber-Hamann B; Kopf D
    Psychother Psychosom; 2010; 79(2):123-5. PubMed ID: 20090399
    [No Abstract]   [Full Text] [Related]  

  • 33. Modafinil augmentation of mirtazapine in a failure-to-thrive geriatric inpatient.
    Schillerstrom JE; Seaman JS
    Int J Psychiatry Med; 2002; 32(4):405-10. PubMed ID: 12779190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is a rational antidepressant treatment for major depression in patients with Parkinson's disease?
    Hagikura M; Iwamoto K; Aleksic B; Ozaki N
    Psychiatry Clin Neurosci; 2012 Aug; 66(5):463. PubMed ID: 22834671
    [No Abstract]   [Full Text] [Related]  

  • 35. Review of the use of mirtazapine in the treatment of depression.
    Benjamin S; Doraiswamy PM
    Expert Opin Pharmacother; 2011 Jul; 12(10):1623-32. PubMed ID: 21644844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of pulmonary thromboembolism and rhabdomyolysis during therapy with mirtazapine and risperidone.
    Zink M; Knopf U; Argiriou S; Kuwilsky A
    J Clin Psychiatry; 2006 May; 67(5):835. PubMed ID: 16841636
    [No Abstract]   [Full Text] [Related]  

  • 37. Mirtazapine-induced hepatocellular-type liver injury.
    Kang SG; Yoon BM; Park YM
    Ann Pharmacother; 2011 Jun; 45(6):825-6. PubMed ID: 21666084
    [No Abstract]   [Full Text] [Related]  

  • 38. Mirtazapine treatment of obsessive-compulsive disorder.
    Koran LM; Quirk T; Lorberbaum JP; Elliott M
    J Clin Psychopharmacol; 2001 Oct; 21(5):537-9. PubMed ID: 11593084
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of newer antidepressants on low-density lipoprotein cholesterol levels.
    Le Mellédo JM; del Pilar Castillo Abadia M; Newman S; Bailey D; Tsuyuki R; Gyenes G
    J Clin Psychiatry; 2004 Jul; 65(7):1017-8; author reply 1018. PubMed ID: 15291694
    [No Abstract]   [Full Text] [Related]  

  • 40. Selection of an antidepressant: mirtazapine.
    Preskorn SH
    J Clin Psychiatry; 1997; 58 Suppl 6():3-8. PubMed ID: 9227668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.